Menatetrenone
 |
| Systematic (IUPAC) name |
| 2-methyl-3-[(2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]naphthoquinone |
| Clinical data |
| AHFS/Drugs.com |
International Drug Names |
| Pregnancy cat. |
? |
| Legal status |
? |
| Routes |
Oral |
| Identifiers |
| CAS number |
863-61-6 |
| ATC code |
None |
| PubChem |
CID 5282367 |
| UNII |
27Y876D139  Y |
| KEGG |
D00100 Y |
| Synonyms |
3-methyl-2-[(2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione |
| Chemical data |
| Formula |
C31H40O2 |
| Mol. mass |
444.648 g/mol |
 Y (what is this?) (verify)
|
Menatetrenone (INN), also known as MK4, is a menaquinone compound used as a hemostatic agent and as adjunctive therapy for the pain of osteoporosis. It is marketed for the latter indication in Japan by Eisai Co., under the trade name Glakay.
Menatetrenone (MK4) is one of the nine forms of vitamin K2.[1]
[edit] See also
[edit] References
[edit] External links
|
|
|
| Fat soluble |
|
|
|
|
|
|
D2 ( Ergosterol, Ergocalciferol#) · D3 ( 7-Dehydrocholesterol, Previtamin D3, Cholecalciferol, 25-hydroxycholecalciferol, Calcitriol (1,25-dihydroxycholecalciferol), Calcitroic acid) · D4 ( Dihydroergocalciferol) · D5 · D analogues ( Alfacalcidol, Dihydrotachysterol, Calcipotriol, Tacalcitol, Paricalcitol)
|
|
|
|
|
|
|
|
|
|
|
| Water soluble |
|
|
B1 ( Thiamine#) · B2 ( Riboflavin#) · B3 ( Niacin, Nicotinamide#) · B5 ( Pantothenic acid, Dexpanthenol, Pantethine) · B6 ( Pyridoxine#, Pyridoxal phosphate, Pyridoxamine) · B7 ( Biotin) · B9 ( Folic acid, Dihydrofolic acid, Folinic acid) · B12 ( Cyanocobalamin, Hydroxocobalamin, Methylcobalamin, Cobamamide) · Choline
|
|
|
|
|
|
|
| Combinations |
|
|
|
|
|
|
|
|
(what is this?) (verify)
